期刊文献+

液态芯片技术联合检测IFN-γ和IP-10诊断结核性胸腔积液 被引量:4

Diagnostic Value of Combined Detection of the Level of IFN-γ and IP-10 by Liquid Array Technology in Tuberculous Pleural Effusion
在线阅读 下载PDF
导出
摘要 目的应用液态芯片技术联合检测胸腔积液中干扰素(IFN)-y IFN-y诱导蛋白(IP)-10水平,探讨其在临床快速诊断及鉴别诊断结核性胸腔积液中的应用价值。方法选取渗透性胸腔积液患者,其中结核性胸腔积液组52例;恶性胸腔积液组38例。利用结核感染T细胞斑点试验(T-SPOT.TB)测定其对结核杆菌反应的效应T细胞数量,即斑点形成细胞数(SFCs),同时利用液态芯片技术测定其IFN-y和IP-10水平,通过Logistic逐步回归法评估IFN-y和IP-10联合诊断时的价值,并比较两种诊断方法的价值。结果T-SPOT.TB法诊断结核性胸腔积液的灵敏度为90.38%,特异度为84.21%,ROC曲线下面积(AUC)及95%CI为0.938(0.867~0.978);IFN-y、IP-10联合诊断结核性胸腔积液时的灵敏度为98.08%,特异度为97.37%,AUC及95%CI为0.995(0.951~1.000)。2种诊断方法灵敏度和特异度的差异不明显;2种方法诊断一致性良好(Kappa=0.703);方法间AUC比较差异有统计学意义(z=1.996,P〈0.05),检测IFN-y IP-10水平联合诊断时AUC较大(AUC=0.995)。结论利用液态芯片技术同时检测IFN-y、IP-10水平联合诊断结核性胸腔积液满足了临床快速、准确诊断及鉴别诊断结核性胸腔积液的需要。 Objective To explore the diagnostic value of combined detection of the liquid array technology, interfer- on (IFN)-y and IFN-y-inducible protein (IP)- 10 in the rapid, accurate diagnosis and differential diagnosis of tuberculous pleural effusions. Methods Patients with transudative pleural effusions were divided into tuberculous pleural effusion group (n=52) and malignant pleural effusion group (n=38). The method of T-SPOT.TB was used to detect the number of effec- tor T cells sensitized to Mycobacterium tuberculosis and spot forming cells (SFCs). The liquid array technology was used to detect the level of IFN-y and IP-10. Logistic regression was used to analyze and compare the diagnostic value of the two- method combination. Results The diagnostic sensitivity, specificity and the area under the ROC curve (AUC) of T-SPOT. TB were 90.38%, 84.21%, and 0.938 (95%CI: 0.867-0.978), respectively. The diagnostic sensitivity, specificity and AUC of combined detection of IFN-yand IP-10 were 98.08%, 97.37%, and 0.995 (95%CI: 0.951-1.000), respectively. There was no significant difference in the diagnostic sensitivity and specificity between the two methods, and the diagnostic agreement for the two diagnostic methods was fine (Kappa=0.703). The difference of AUC between the methods was significantly differ- ent (Z=1.996, P 〈0.05). The method of combined detection of IFN-yand IP-10 showed the larger AUC (AUC= 0.995). Con- clusion The combined diagnosis meets the clinical needs of rapid, accurate diagnosis and differential diagnosis for tuber- culous pleural effusion by simultaneously assaying the level of IFN-yand IP-10 using the liquid array technology.
出处 《天津医药》 CAS 北大核心 2014年第9期943-945,共3页 Tianjin Medical Journal
基金 天津市卫生局科技基金项目(2013KZ042)
关键词 干扰素Ⅱ型 趋化因子CXCL10 胸腔积液 恶性 结核 ROC曲线 结核感染T细胞斑点试验 液态芯片 IFN-y诱导蛋白10 interferon type Ⅱ chemokine CXCL10 pleural effusion, malignant tuberculosis ROC Curve T-SPOT.TB liquid array technology IFN-y-inducible protein 10
  • 相关文献

参考文献2

二级参考文献17

  • 1中华人民共和国卫生部.WS288-2008肺结核诊断标准.北京:人民卫生出版社,2008.
  • 2中华人民共和国国家统计局.北京:中国统计年鉴2010.[M].中国统计出版社,2010.
  • 3中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 4中华人民共和国卫生部.2000年全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,2002.
  • 5中华人民共和国卫生部.1979全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,1981.
  • 6中华人民共和国卫生部.1984/1985全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,1988.
  • 7中华人民共和国国务院办公厅国办发[2001]75号.国务院办公厅关于印发全国结核病防治规划(2001-2010年)的通知.2001-11-13.
  • 8中华人民共和国国家统计局.第一次全国经济普查主要数据公报(第一号)[EB/OL].2010[2012-06-12]at:http://www.stats.gov.cn/zjpc/cgfb/t20051206-402294807.htra.
  • 9中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版).北京:中国协和医科大学出版社,2009.
  • 10World Health Organization. Policy guidance on drug-suscepti- bility testing (DST) of second-line anti-tuberculosis drugs. Geneva:WHO, 2008.

共引文献2512

同被引文献67

  • 1中华医学会结核病学会.肺结核诊断和治疗指南[J]中华结核和呼吸杂志,2001(02).
  • 2Kong KO, Tan AW, Thong BY, et al. Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus [J]. Clin Exp Immunol, 2009,156( 1 ) : 134-140.
  • 3Kong KO, Tan AW, Thong BY, et al. Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus [J]. Clin Exp Immunol, 2009,156 ( 1 ) : 134-140.
  • 4Arai Y, Arihiro S, Matsuura T, et al. Pmstaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis [J]. Inflamm Bowel Dis, 2014, 20(7) : 1208-1216.
  • 5Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes [J ]. Inflamm Bowel Dis, 2013,19(2) :332-341.
  • 6Noguchi A, Watanabe K, Narumi S, et al. The production of interferon-gamma-inducible protein 10 by granulocytes and monoeytes is associated with ulcerative colitis disease activity [ J ]. J Gastroenterol, 2007,42 (12) : 947 -956.
  • 7Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUA- DAS : a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews [ J ]. BMC Med Res Methodol, 2003, 3:25.
  • 8王昌敏,陆琳松,张春梅,等.胸腔积液结核感染T细胞斑点试验(T-SPOT.TB)用于结核性胸腔积液(TBPE)诊断的临床价值分析[J].医学信息,2015,28(32):108.
  • 9Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-γ release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China[J]. PLoS One ,2014,9( 1 ) : e85030.
  • 10Losi M, Bossink A, Codecasa L, et al. European Tuberculosis Network TBNET. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy [J]. Eur Respir J,2007,30 (6) : 1173-1179.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部